Wow.
This is amazing news.
Oncosil gets sales and a fully funded RCT: this is worth potentially tens of millions of dollars to the company.
Further, it may add to the evidence dossier required by the FDA, TGA and NICE in the UK. And, as they say, it will start to generate interest in clinicians generally in private use.
This deal is probably worth the current market value, so the market needs to catch up.
Ann: Fully-Funded Trial Approved In Germany, page-3
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.40M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.2¢ | 1.1¢ | $92.50K | 7.934M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 4566639 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 7725812 | 7 |
View Market Depth
| Last trade - 16.10pm 07/08/2024 (20 minute delay) ? |
| OSL (ASX) Chart |